Upgrade to SI Premium - Free Trial

Oppenheimer on Compass Pathways (CMPS): 'we see increasing focus on additional COMP360 opportunities beyond TRD'

August 5, 2026 2:17 PM
Oppenheimer analyst Francois Brisebois reiterated an Outperform rating and $20.00 price target on Compass Pathways (NASDAQ: CMPS)The analyst comments "We ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Hot Comments